Agilon Health Inc (NYSE:AGL) saw a downside of -2.93% to $18.25 after subtracting -$0.55 on Wednesday. The 5-day average trading volume is 1,796,091 shares of the company’s common stock. It has gained $18.98 in the past week and touched a new high 4 times within the past 5 days. An average of 1,984,483 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,235,551.
AGL’s 1-month performance is 7.16% or $1.03 on its low of $16.94 reached on 08/29/23. The company’s shares have touched a 52-week low of $15.00 and high of $29.44, with the stock’s rally to the 52-week high happening on 03/27/23. YTD, AGL has achieved 13.07% or $2.11 and has reached a new high 25 times. However, the current price is down -38.01% from the 52-week high price.
Insider Transactions
AGL stock investors last saw insider trading activity on Sep 13.Shaker Benjamin (Chief Markets Officer) most recently sold 18,750 shares at $18.00 per share on Sep 13. This transaction cost the insider $337,455. Chief Markets Officer, Shaker Benjamin, sold 18,750 shares at a price of $18.05 on Sep 12. Then, on Sep 11, Chief Accounting Officer Gertsch Timothy sold 26,250 shares at a price of $18.61 per share. This transaction amounted to $488,616.
Valuation Metrics
AGL stock has a beta of 0.91. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.02 while the price-to-book (PB) in the most recent quarter is 8.41.
Agilon Health Inc’s quick ratio for the period ended June 29 was 1.50, with the current ratio over the same period at 1.50. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.05, while the total debt to equity was 0.06. In terms of profitability, the gross margin trailing 12 months is 4.18%. The trailing 12-month EBITDA margin is -3.85% while for the period ending June 29, Agilon Health Inc’s operating margin was -3.31%. The firm’s gross profit as reported stood at $112.29 million against revenue of $2.71 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -23.28% to -$16.75 million, while revenue of $16.02 million was 195.64% off the previous quarter. Analysts expected AGL to announce -$0.02 per share in earnings in its latest quarter, but it posted -$0.04, representing a -100.00% surprise. EBITDA for the quarter stood at more than -$24.31 million. AGL stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 1.47 billion, with total debt at $50.97 million. Shareholders hold equity totaling $405.48 million.
Let’s look briefly at Agilon Health Inc (AGL) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 26 September was 49.38% to suggest the stock is trending Neutral, with historical volatility in this time period at 31.92%.
The stock’s 5-day moving average is $18.47, reflecting a +0.72% or $0.13 change from its current price. AGL is currently trading +3.75% above its 20-day SMA, -24.87% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +4.58% and SMA200 by+5.31%.
Stochastic %K and %D was 69.85% and 71.41% and the average true range (ATR) pointed at 0.69. The RSI (14) points at 50.29%, while the 14-day stochastic is at 48.23% with the period’s ATR at 0.71. The stock’s 9-day MACD Oscillator is pointing at 0.07 and 0.17 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Agilon Health Inc (NYSE: AGL), Evercore ISI launched coverage with an In-line rating. Analysts offering their rating for AGL stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate AGL as a “sell,”, while 2 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 13 have offered a “buy” rating.
What is AGL’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $21.00 and a high of $41.00, with their median price target at $28.00. Looking at these predictions, the average price target given by analysts is for Agilon Health Inc (AGL) stock is $28.92.
